GYRE
Gyre Therapeutics Inc.
7.30$
-2.3%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.5% | -77.2% | +155.1% | -99.4% | – | – | -65.0% | +1,294.0% | +10.9% | -6.8% | +10.2% | |
| – | +13.1% | +77.2% | -98.4% | -13.9% | -2.0% | +6,176.0% | -16.3% | -37.5% | -3.3% | -16.2% | +39.4% | |
| – | – | – | – | -116.9% | – | – | -102.8% | – | +11.6% | -6.4% | +9.1% | |
| – | +13.1% | +93.9% | +11.2% | +67.2% | +104.2% | +20.8% | +21.9% | -74.2% | -17.4% | -12.7% | +13.9% | |
| – | +136.6% | -3.5% | +7.9% | +23.6% | +8.6% | +20.6% | +16.3% | -7.7% | -15.6% | +9.9% | +29.1% | |
| – | +80.0% | +33.9% | +8.9% | +49.2% | +68.9% | +21.0% | +20.6% | +5.9% | +99.4% | -51.3% | +16.3% | |
| – | – | – | – | – | – | – | – | – | -830.5% | – | -29.2% | |
| – | +6,326.1% | – | – | – | – | – | – | +224.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -917.7% | – | -37.8% | |
| – | -85.1% | +495.4% | -105.6% | – | -160.8% | – | – | – | +67.0% | -37.5% | -14.4% | |
| – | – | – | – | – | – | – | – | – | -4,137.1% | – | -58.4% | |
| – | – | – | – | – | – | – | – | – | +92.8% | -12.3% | -4.8% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.